Background. Serum sodium is commonly measured by direct potentiometry (D Na ), in blood gas panels, or indirect potentiometry (I Na ), in metabolic panels run on chemistry analyzers. Abnormal values of the serum non-water fraction interfere with I Na , with low values causing pseudohypernatremia (I Na > D Na ) and high values causing pseudohyponatremia (I Na < D Na ). Previous attempts to derive a linear correction for the difference between I Na and D Na (ΔNa) arising from nonwater bias-using serum total protein (TP) or albumin (ALB) to represent the non-water fraction-have yielded inconsistent results, possibly owing to differences in sample inclusion criteria, analytic platforms and statistical approach. Methods. We quantified the effects of TP and ALB on ΔNa in 774 critical care patients with closely timed metabolic and gas panels, adjusting for other known effects. Results. ΔNa varied inversely with TP, ALB, and the glucose difference between chemistry and gas panels (ΔGlu), and directly with pH and bicarbonate. The effect of TP on ΔNa was essentially linear, but that of ALB was not; hence, further analysis focused on TP. By multiple linear regression, ΔNa decreased by 0.64 ± 0.06 mEq/L for each 1 g/dL increase in TP, adjusted for ΔGlu, pH, and regression to the mean; the TP effect was slightly steeper (0.69 ± 0.06 mEq/L), when adjusted for bicarbonate instead of pH. Conclusions. For each 1 g/dL rise or fall in TP, clinicians may find it useful to adjust I Na by 0.7 mEq/L in the same direction in order to correct I Na for non-water bias.
I N T RO D U C T I O N
Precision and accuracy in the measurement of serum sodium concentration are essential for the diagnosis and safe treatment of the dysnatremias [1] . In the era when serum sodium was measured by flame photometry (F Na ), clinicians were aware of pseudohyponatremia, a spuriously low F Na resulting from the water exclusion effect, which occurs when the percent of a serum sample's volume occupied by the substances which exclude water and electrolytes-i.e. lipids and colloidal proteins-exceeds the usual value of 7% [2] [3] [4] . The opposite artifact, pseudohypernatremia, occurring when the non-water fraction falls below normal [4] [5] [6] [7] [8] , was overlooked by clinicians, even though a version of this artifact, resulting from sample deproteination by filtration, had been described long before the advent of flame photometry [9] .
Currently sodium is measured with ion-selective electrodes, using either the indirect method (I Na ) on automated chemistry analyzers, or the direct method (D Na ) on blood gas analyzers [4, 6] . Since the indirect method involves pre-analytic dilution and assumes a non-water fraction of 7%, it retains the very same sensitivity to the water exclusion effect as the older flame method [4, 6, [10] [11] [12] . Consequently, an entirely spurious difference between simultaneous I Na and D Na measurements (ΔNa) may arise when the non-water fraction of serum is not 7% and, similarly, between sequential I Na measurements if the non-water fraction changed between measurements. It would be useful indeed if this frequent source of bias could be corrected by a simple linear equation based on the serum concentration of either of the commonly measured colloid levels, albumin (ALB) and total protein (TP), in a manner similar to
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the adjustment of serum sodium for serum glucose [13] , and to the adjustment of the anion gap and serum total calcium for ALB [14, 15] .
A number of theoretical and empirical studies have attempted to quantify the effect of changes in either ALB or TP on either I Na , F Na , or ΔNa [5, 6, 11, 12, [16] [17] [18] [19] [20] [21] [22] (Supplementary data, Table S1 ). The observational studies produced disparate estimates of these effects and even differ on whether the effects are linear or not. While this heterogeneity may stem from differences in study characteristics (study size, enrollment criteria, blood sample type, analytic platforms), it also may reflect the potentially inadequate handling of important statistical issues. For example, the studies are largely silent on the validation of modeling assumptions, and on their approaches to the spurious variation that results from regression to the mean [23] , and, as noted by Jones and Twomey [20] , to repeat (i.e. non-independent) measures [24] (Supplementary data, Table S1 ). The one study, by Dimeski et al. [21] , that clearly addressed those statistical issues, treated TP only as a categorical variable, and did not examine ALB at all. Consequently, a statistically valid linear correction for non-water bias based on either TP or ALB remains to be established. Additionally, none of these studies adjusted for possible confounding by the tendency of increasing pH and/or bicarbonate concentrations to depress D Na and thus increase ΔNa [8, [25] [26] [27] [28] , even though disturbances of acid-base status are common in critically ill patients.
The purpose of the present study was to derive linear estimates of the effects TP and ALB on ΔNa in a large set of retrospectively collected pairs of I Na and D Na measurements, all made under 20 min apart in a critical care setting over a 3-year period, with testing for nonlinearity, avoidance of repeat measures, and adjustment for regression to the mean and for other known influences on ΔNa.
M AT E R I A L S A N D M E T H O D S

Patients
All patients admitted to a critical care unit (intensive, coronary, surgical) of the Veterans Affairs New York (NY) Harbor Healthcare System (consisting of NY and Brooklyn (BK) campuses) between 1 January 2009 and 31 December 2011 were eligible. The protocol was approved by the institutional review board.
Analytic methods
Metabolic panel measurements of serum I Na , glucose (sGlu), total carbon dioxide (tCO 2 ), TP and ALB were performed on the ADVIA Chemistry System 1650 (A1650) analyzer (Siemens Healthcare Diagnostics, Tarrytown, NY) from 1 January 2009 until 31 March 2011 at the BK campus and until 27 May 2011 at the NY campus, after which the ADVIA Chemistry System 1800 (A1800) was used. The I Na assay is calibrated daily, reports results as whole numbers and has a linear range of 100-200 mEq/L; the expected coefficient of variation (CV) varies by analyzer (A1650: 1.8% A1800: 0.6%). The other assays' linear ranges (CV) are: sGlu, 0-1190 mg/dL (0.8%); tCO 2 , 10-40 mEq/L (3.5%); TP, 2.0-12.0 g/dL (1.8%); ALB (bromocresol green), 1.0-6.0 g/dL (1.8%). Gas panel measurements of D Na , glucose (gGlu) and pH were performed on the ABL800 FLEX blood gas analyzer (Radiometer, Copenhagen) on heparinized whole blood samples collected using the safePICO sampler (Radiometer). The D Na assay is calibrated every 4 h, reports results as whole numbers and has a linear range (CV) of 7-350 mEq/L (0.9%). The other assays' linear ranges (CV) are: gGlu, 0-1081 mg/dL (6%); pH, 6.3-8.0 (0.11%). The gas panel bicarbonate concentration (gHCO 3 ) is calculated with the Henderson-Hasselbalch equation.
Data selection and pairing A data abstraction program searched the hospitals' computerized laboratory database and retrospectively collected every metabolic and blood gas panel originating from a critical care unit during 2009-2011. Metabolic panels were excluded if they lacked I Na , sGlu or ALB; hemolysis or lipemia was reported; or if sGlu exceeded 1081 mg/dL (the upper limit of the gGlu assay). Blood gas panels were excluded if they lacked D Na or gGlu. The abstracted data did not indicate whether the gas sample was arterial or venous.
If a gas panel and a metabolic panel of a given patient had been registered under 20 min apart, they were paired. This short time limit minimized the impact of ongoing therapy on serum sodium, and the chance that the latter member of a pair was collected specifically to confirm an abnormal sodium in the former, while allowing sufficient cases for estimate precision. No patient or panel was used twice. If a gas panel could be paired with two metabolic panels (or vice versa), the pair with the briefest time difference was selected; in case of a tie, the earlier pair was used. For each patient, the single pair with the briefest time difference was retained; in case of ties, the earliest pair was chosen. While review of the clinical events at the time of blood sampling for every pair was not feasible, we screened the pairs for unreliable data by comparing the four analytes shared by both panels (i.e. sodium, potassium, bicarbonate, glucose). If two or more shared analytes were markedly discordant, we examined the clinical context at the time of sampling, and excluded the pair if there was an extremely obvious clinical explanation for the discordance, i.e. (i) sampling during an acute event associated with rapid changes in water and cation balance [29, 30] or in glucose concentration [13] (e.g. during acute treatment of hypoglycemia, resuscitation for cardiac arrest or hemodialysis) or (ii) clear contamination of the serum sample by a fluid infusion distal to the phlebotomy site.
After exclusions, 774 paired panels remained; one pair lacked a TP value. The median registration time difference within each pair was 4 min (0-19 min). For sensitivity analyses, the pairs were divided into three subgroups based on the time difference: 0-1 min (n = 169); 2-5 min (n = 283); 6-19 min (n = 322).
Statistical methods and data analysis
Continuous variables are presented as the mean ± standard deviation (SD) and compared with the paired or unpaired t-test or ANOVA. Variances (SD Regression coefficients are presented as the mean ± standard error (SE) or the mean and 95% confidence interval (95% CI).
The target of the analysis, ΔNa, was computed as I Na minus D Na . Since I Na and D Na were whole numbers, ΔNa values were integers. Mean ΔNa estimates the bias between I Na and D Na assays. Inconsistency of the bias across the range of sodium values was tested by correlating ΔNa with the sum of I Na and D Na [31] . ΔGlu was computed as sGlu minus gGlu. The expected associations of ΔNa with TP, ALB, ΔGlu, tCO 2 , and pH, and possible associations with chemistry analyzer and registration time difference were tested. Next, the trend of ΔNa was examined across TP and ALB, divided into categories, by ANCOVA with D Na as a covariate to adjust for regression to the mean [23] . As in prior studies [19, 21] , the TP categories were made 1 g/dL wide, ∼90% of the SD of TP. For consistency, the ALB category width was chosen to approximate 90% of the SD of ALB (i.e. 0.7 g/dL). Nonlinear effects were sought by modeling the categories with polynomial contrast, a method which simultaneously tests linear and nonlinear (quadratic and higher order) effects. If the effect of either ALB or TP was essentially linear, it was next treated as a continuous variable and its effect estimated by multiple linear regression, adjusted for D Na , ΔGlu, pH or tCO 2 , and other potential confounders. Modeling assumptions were tested, including residual analysis and testing for interactions. Statistical tests were performed using SPSS 17.0 (Chicago, SPSS Inc.).
R E S U LT S
Baseline data and simple comparisons The I Na assay was positively biased relative to the D Na assay (Supplementary data, Figure S1 ). The bias (mean ΔNa) was ); the variance of mean ΔNa declined with the change (P < 0.002), consistent with the imprecision data of the manufacturer. ΔNa did not significantly correlate with the sum of I Na and D Na overall or in either analyzer subgroup. Mean ΔNa did not differ in three registration time subgroups. The mean values and ranges of all the analytes are listed in Supplementary data, Table S2 . SGlu was incidentally noted to be negatively biased relative to gGlu (ΔGlu: −6.9 ± 18.0 mg/dL, P < 10 −24 ). ΔNa showed inverse associations of a clinically relevant size with TP (ΔNa = 6.2-0.60 × TP, P < 10 −17 ; Figure 1 ), ΔGlu (ΔNa = 2.1-0.026 × ΔGlu, P < 10
) and ALB (ΔNa = 3.8-0.41 × ALB, P < 10
). Modest direct effects on ΔNa were also found for both pH (ΔNa = −17.3 + 2.7 × pH, P < 0.01) and tCO 2 (ΔNa = 1.4 + 0.036 × tCO 2 , P < 0.01). TCO 2 also varied directly with both TP (tCO 2 = 18.9 + 1.0 × TP, P < 10 −6 ) and ALB (tCO 2 = 18.6 + 1.9 × ALB, P < 10
) raising the possibility of confounding. Neither TP nor ALB varied with pH.
Multivariable analysis of ΔNa trend
Mean ΔNa declined consistently across the range of TP values, divided into uniform categories (P < 10 −14 ; Table 1 ). When TP category was modeled using polynomial contrast, only the linear component was significant (P < 10 −11 ). Mean ΔNa also declined across ALB categories (P < 10
, Table 1 ), but far less uniformly, with little change evident in the range of 2.0-4.1 g/dL, a pattern evident in three independent subgroups, defined by registration time (Supplementary data, Figure S2 ). Trend analysis indicated statistically significant linear (P < 10 −4
) and cubic (P < 0.02) components to the effect of ALB category. Since TP was a much stronger and more ). The regression lines differ statistically in y-intercept (P < 0.01) but not in slope (P > 0.4). 
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clearly linear predictor of ΔNa than was ALB, further analysis focused exclusively on TP.
When the independent effects of TP, ΔGlu and analyzer were estimated by multiple linear regression (Supplementary data, Table S3 ), ΔNa fell by a mean of 0.64 mEq/L (95% CI: 0.51-0.76 mEq/L) with each 1 g/dL rise in TP, adjusted for the effects of ΔGlu (a mean fall of 2.7 mEq/L per 100 mg/dL increase in ΔGlu) and analyzer (a mean rise of 0.46 mEq/L with the switch to the A1800). When pH was added to this model, the effects of TP, ΔGlu and analyzer were virtually unchanged, while each 1.0 unit increase in pH independently increased ΔNa by 2.0 mEq/L (95% CI: 0.32-3.6 mEq/L). Table 2 shows the effect of TP adjusted for ΔGlu, tCO 2 and analyzer. Compared to the prior models, the estimated effect of TP was slightly steeper [mean fall of 0.69 mEq/L (95% CI: 0.57-0.82 mEq/L)], the effects of ΔGlu and analyzer were not significantly altered and each 10 mEq/L increase in tCO 2 independently increased ΔNa by a mean of 0.6 mEq/L. The estimated effect of TP was not significantly changed in these models when the two most extreme values of ΔNa were excluded, or when the three registration time subgroups were examined separately.
D I S C U S S I O N
Discordance between assays can result from measurement error, including random error (imprecision), calibration bias and interference specific to one assay. Selective interference with I Na , but not with D Na , is known to occur when the non-water fraction of serum deviates from its usual value of 7% [4, 6] . Theoretical and experimental work suggested that the difference between indirect and direct measurements of sodium arising from non-water bias should decrease by ∼1 mEq/L for each 1 g/dL increase in TP [5, 6, 16] . Observational studies, however, have differed markedly in their estimates of the effects of TP and ALB on ΔNa. For example, a 1 g/dL increase in TP has been reported to have no effect on ΔNa [18] , or to cause a linear decrease of 0.7, 1.2 or 1.4 mEq/L [17, 19, 20] , or to have a nonlinear effect [11] (Supplementary data, Table S1 ). The exact source of this variation is unclear, as the studies differed in many ways, including the handling of several statistical issues, as reviewed earlier. The present study quantified the effects of TP and ALB on ΔNa, in a large retrospective database of critical care patients, with testing for nonlinearity, avoidance of repeat measures, and adjustment for regression to the mean and other known influences on ΔNa. Figure S2) , and trend analysis suggested the relationship was best described by a cubic model. Dimeski and Barnett [11] also found this relationship to be nonlinear. It might be expected that ALB would not correlate in a simple manner with the non-water fraction of serum in critically ill patients, in whom a fall in ALB tends to be offset by a reciprocal increase in acute-phase proteins [32] . We found that mean ΔNa declined consistently across TP categories (Table 2) , similar to the categorical analysis by Dimeski et al. [21] . When we treated TP as a continuous variable, ΔNa decreased by 0.64 mEq/L (95% CI: 0.51-0.76 mEq/L) to 0.69 mEq/L (0.57-0.82 mEq/L) for each 1 g/dL increase in TP, depending on the covariates. The effect of TP was consistent in three independent registration time subgroups, and was also similar to the estimate of 0.7 mEq/L reported by Chow et al. [19] . Unlike prior studies, the present analysis also adjusted for the effects on ΔNa of pH or tCO 2 , the estimates of which were consistent with prior studies [8, 27, 28] . While some of the variability of the TP effect in prior studies might reflect the variety of chemistry and gas analyzers employed [33] , we found it to be similar on two different chemistry analyzers, albeit from the same manufacturer (Figure 1) . In any event, future studies should test a variety of different analytic platforms concurrently. When it is clinically important to attenuate the bias in I Na because the serum non-water fraction is abnormal or changing, a practical approach at present would be to subtract 0.7 mEq/L from I Na for each 1 g/dL fall in TP (or to add 0.7 mEq/L for each 1 g/dL increase in TP). For example, dilution of TP is predictable when crystalloids are infused intravenously to treat hyponatremia, or when water shifts out of cells in response to a rise in serum glucose. Correcting the resulting bias in I Na will improve accuracy in calculating the treatment rate of hyponatremia, and in estimating the fall in I Na to be expected when glucose rises [34] . Although the interchangeable use of I Na and D Na data has been discouraged [35] , we suggest that it can be done by adjusting I Na to the value it would have at that TP concentration at which non-water bias is zero (TP 0 ). For example, if TP 0 is 10 g/dL, its approximate value in our study ( Figure 1, Table 1 ), then adjusted I Na can be computed as: observed I Na + 0.7 × [TP −10] . The residual bias between D Na and adjusted I Na is, not surprisingly, minimal in our entire sample (−0.14 ± 2.1 mEq/L) and in two analyzer subgroups (A1650: −0.28 ± 2.3 mEq/L; A1800: 0.25 ± 1.5 mEq/L). Unfortunately, the value of TP 0 varied widely among recent studies (5.0 g/dL [20] , 7.5 g/dL [21] , 10.3 g/dL [19] ), implying interassay calibration bias. Broughton et al. reported similarly wide variability of TP 0 in comparing several D Na assays with one F Na assay, leading the authors to propose that manufacturers calibrate assays to a TP 0 of 7 g/dL [17] .
ALB varied inversely with
Incidentally noted in the present study was that sGlu was 6.9 mg/dL lower, on average, than gGlu. Bias of this magnitude and direction has been reported [36, 37] . While this may simply be calibration bias, it could also reflect a true arterio-venous glucose gradient [38, 39] , or in vitro glucose consumption in metabolic panel samples, which take longer to process [39] .
One limitation of the present study is the presence of sources of ΔNa other than measurement error. Since the paired samples were not necessarily simultaneous, some of the differences between I Na and D Na may be the result of a true change, resulting from changes in glucose concentration [13] or in cation and water balance [29, 30] . The regression models accounted for glucose, but not for water and cation balance; the resulting unexplained variance will tend to reduce the precision of the models. Another potential concern is selection bias because the data were retrospective. This bias should be minimal, however, because metabolic and gas panels are routinely obtained in every critical care patient in our institution, every such panel was captured by the software we employed and each patient was limited to one pairing. Generalizability may be a concern since the focus of our study, as of most prior studies, was critically ill patients, who also tend to be hypolipidemic. It is possible that TP may less closely represent the non-water fraction of serum in less seriously ill, normolipidemic, patients. However, as Sepulveda noted, the impact of TP on the nonwater fraction tends to be much greater than that of lipids, owing to the wider absolute range of TP values observed in the clinical setting [40] . In summary, the water exclusion effect interferes with I Na measurements, causing a spurious difference to arise between I Na and D Na . We found this difference increases linearly by ∼0.7 mEq/L with each 1 g/dL decrease in TP, a ratio that may be clinically useful when correction of I Na for non-water bias is needed. But the exact TP value at which any given pair of I Na and D Na assays yields equivalent results is likely to vary by institution, implied by the finding, in prior work and our study, that I Na and D Na assays also differ by a constant or intercept bias, the value of which depends on the specific commercial assays being compared.
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